Venezuelan-based residential and business network provider upgrades MikroTik with OcNOS for enhanced Edge and Aggregation Routing
SANTA CLARA, Calif., May 14, 2024 – IP Infusion, a global leader in open networking solutions, today announced that Venezuelan-based network service provider Netcom Plus has deployed IP Infusion software products with hardware from Edgecore and UfiSpace to upgrade its backbone network to accommodate modern bandwidth and new features. This deployment is a significant upgrade to an existing MikroTik installation, a configuration that could no longer accommodate current service demands or growth.
Netcom Plus evaluated various upgrade options from vendors including Cisco, SONiC, and Cumulus. While cost was a significant factor, the other solutions also lacked the advanced Service Provider features Netcom Plus required: VPLS tunnels, Layer 2 features, BGP, and OSPF routing. In addition, by deploying OcNOS on Edgecore and UfiSpace networking hardware, Netcom Plus was able to dramatically increase bandwidth capacity, from 10-20 Gbps to an upper capacity of 2.4Tbps.
“It was clear the IP Infusion solution beat out the competition on features alone. When you factor in cost, the choice was obvious,” said Hugo Araujo, CTO for Netcom Plus. “MikroTik is old hardware and software, old processors. OcNOS feels like driving a new car, and the upgrade was plug-and-play directly through IP Infusion.”
“The service provider market will always be important to IP Infusion,” said Atsushi Ogata, President and CEO of IP Infusion. “Because we work closely with our top-tier client partners, listening to their needs, and providing tailored, cost-effective solutions, we have become the premier one-stop shop for the complete networking needs of any organization.”
About IP Infusion
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform OcNOS® allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs can also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
Media Contact:
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
About IP Infusion
IP Infusion is a leading provider of open networking software, delivering OcNOS, a carrier-grade network operating system for service providers, data centers, and AI fabric networks. With networking expertise since 1999 and 600+ operators worldwide, IP Infusion enables open, multi-vendor, cost-efficient, and flexible network infrastructure on validated open hardware from partners including Edgecore Networks, UfiSpace, and Celestica. IP Infusion is a wholly owned subsidiary of ACCESS CO., LTD. (Tokyo Stock Exchange: 4813).
Media Contact
For press inquiries, analyst briefings, or media materials, please contact our team or email pr@ipinfusion.com.
Forward-Looking Statements
This release may contain forward-looking statements regarding IP Infusion products, technology, and plans. Forward-looking statements are based on information available as of the publication date and involve risks and uncertainties. Actual results may differ. Product plans, features, release timing, and availability are subject to change without notice and do not constitute a commitment, promise, or legal obligation. IP Infusion undertakes no obligation to update any forward-looking statement.